You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Patent: 9,707,154


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,707,154
Title:Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
Abstract: The present invention is based, at least in part, on the identification of a pharmaceutical container formed, at least in part, of a glass composition which exhibits a reduced propensity to delaminate, i.e., a reduced propensity to shed glass particulates. As a result, the presently claimed containers are particularly suited for storage of pharmaceutical compositions and, specifically, a pharmaceutical solution comprising a pharmaceutically active ingredient, for example, LUCENTIS.RTM. (ranibizumab), BEXSERO.RTM. (meningococcal group B vaccine [rDNA, component, adsorbed]), AIN457 (secukinumab) or RELAXIN.RTM. (serelaxin).
Inventor(s): Weeks; Wendell P. (Corning, NY), Schaut; Robert Anthony (Painted Post, NY), DeMartino; Steven Edward (Painted Post, NY), Peanasky; John Stephen (Big Flats, NY)
Assignee: Corning Incorporated (Corning, NY)
Application Number:14/259,270
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of United States Patent 9,707,154

Introduction

United States Patent 9,707,154, hereafter referred to as the '154 patent, is a significant intellectual property asset that requires a thorough analysis to understand its claims, patentability, and position within the broader patent landscape. This analysis will delve into the patent's details, its legal and technical aspects, and its implications for innovation and competition.

Background of the Patent

To begin, it is essential to understand the context in which the '154 patent was granted. The patent application process involves several stages, including filing, examination, and potential office actions[3].

Claims and Description

The '154 patent includes a set of claims that define the scope of the invention. These claims must be novel, non-obvious, and useful to be patentable[3].

Claim Analysis

Each claim in the '154 patent should be scrutinized to determine its novelty and non-obviousness. This involves comparing the claims against prior art to ensure that the invention does not merely combine existing technologies in an obvious way[3].

Description and Drawings

The patent's description and drawings provide detailed information about the invention. These sections are crucial for understanding how the invention works and its specific features.

Patentability Requirements

For a patent to be granted, it must meet several key requirements:

Novelty Requirement

The invention must be new and not previously disclosed in the prior art. This means that every element of the claimed invention must not be identically disclosed in any prior publication or public use before the effective filing date of the patent application[2].

Nonobviousness Requirement

The invention must be non-obvious, meaning it must not be an obvious combination of existing technologies. The patent claims must contain elements sufficient to ensure that the patent in practice amounts to significantly more than a patent upon the ineligible concept itself[2].

Usefulness Requirement

The invention must be useful, meaning it must have a practical application or be capable of being used for a specific purpose[3].

Prior Art and Prosecution History

The file wrapper or prosecution history of the '154 patent provides valuable insights into the examination process. This includes the arguments made between the patent applicant and the examiner, prior art citations, and any office actions or responses[3].

File Wrapper Analysis

Reviewing the file wrapper can reveal how the patent applicant addressed examiner objections and how the claims were narrowed or modified to overcome prior art. This information is crucial for understanding the patent's strength and potential vulnerabilities[3].

Patent Landscape Analysis

To position the '154 patent within the broader patent landscape, it is necessary to conduct a patent landscape analysis.

Competitive Intelligence

Analyzing the patent landscape involves identifying other patents in the same technological field. This helps in understanding the competitive environment, identifying white spaces for innovation, and assessing the barriers to entry[5].

Citation Analysis

Examining patent citations can provide insights into how the '154 patent relates to prior and subsequent innovations. This analysis can help gauge the importance of the patent within its technological field[5].

Patent Family Analysis

Analyzing the patent family of the '154 patent can determine its geographical coverage and whether it has been filed in multiple countries. This is essential for understanding the global reach and protection of the invention[5].

Legal and Regulatory Compliance

The '154 patent must comply with all relevant legal and regulatory requirements.

PTAB and Inter Partes Review

The Patent Trial and Appeal Board (PTAB) and inter partes review (IPR) processes are critical for challenging the validity of patents. Understanding how these processes work can help in assessing the patent's vulnerability to challenges and the potential for litigation[2].

Impact on Innovation and Competition

The '154 patent can have significant implications for innovation and competition in its field.

Innovation

By protecting a novel and non-obvious invention, the '154 patent can incentivize further innovation. However, it can also create barriers to entry for other innovators if the claims are overly broad or if the patent is used to stifle competition[2].

Competition

The patent can influence the competitive landscape by granting exclusive rights to the patent holder. This can lead to licensing opportunities, mergers and acquisitions, and strategic partnerships. However, it can also be a subject of litigation if competitors challenge its validity[5].

Valuation and Strategic Decisions

The '154 patent can be a valuable asset for its holder, influencing strategic decisions such as licensing, mergers and acquisitions, and R&D strategies.

Intellectual Property Valuation

Patent analysis is crucial for valuing intellectual property portfolios. The '154 patent's value can be assessed based on its novelty, non-obviousness, and market relevance[5].

R&D Strategy

Analyzing the '154 patent can help organizations refine their R&D strategies by identifying areas of innovation and potential white spaces in the technological field[5].

Technology Transfer

The '154 patent can facilitate technology transfer by identifying technologies with commercial potential and aiding in the transfer of knowledge from research settings to the marketplace[5].

Key Takeaways

  • Patent Claims: The '154 patent's claims must be carefully analyzed to ensure they meet the requirements of novelty, non-obviousness, and usefulness.
  • Prosecution History: The file wrapper provides critical insights into the patent's examination process and its strength.
  • Patent Landscape: Analyzing the patent landscape helps in understanding the competitive environment and identifying opportunities for innovation.
  • Legal Compliance: The patent must comply with legal and regulatory requirements, including the potential for challenges through PTAB and IPR.
  • Impact on Innovation and Competition: The patent can influence innovation and competition by granting exclusive rights and creating barriers to entry.

FAQs

Q: What is the significance of the file wrapper in patent analysis?

The file wrapper contains detailed discussions between the patent applicant and the examiner, prior art citations, and office actions, which are essential for understanding the patent's prosecution history and its strength.

Q: How does the PTAB affect patent validity challenges?

The PTAB provides a faster and less expensive process for challenging patent validity compared to federal court litigation, requiring a lower burden of proof to invalidate patents.

Q: What is the role of prior art in patent analysis?

Prior art is crucial for determining the novelty and non-obviousness of a patent. It involves identifying existing technologies or innovations that may affect the validity or patentability of a new invention.

Q: How can patent landscape analysis benefit businesses?

Patent landscape analysis helps businesses understand the competitive landscape, identify white spaces for innovation, and make informed decisions about entering new markets or expanding existing ones.

Q: What is the importance of citation analysis in patent evaluation?

Citation analysis helps gauge the importance of a patent within its technological field by examining how the patent relates to prior and subsequent innovations.

Cited Sources

  1. US 2020/0047288 A1 - Additive Manufacturing Processes and Additively Manufactured Products.
  2. Congressional Research Service - The Patent Trial and Appeal Board and Inter Partes Review.
  3. IP Checkups - Patent file wrappers as a tool for competitive intelligence.
  4. USPTO - Search for patents.
  5. Evalueserve - Patent Analysis.

More… ↓

⤷  Subscribe

Details for Patent 9,707,154

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 June 30, 2006 ⤷  Subscribe 2033-04-24
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 August 10, 2012 ⤷  Subscribe 2033-04-24
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 October 13, 2016 ⤷  Subscribe 2033-04-24
Genentech, Inc. LUCENTIS ranibizumab Injection 125156 March 20, 2018 ⤷  Subscribe 2033-04-24
Novartis Pharmaceuticals Corporation COSENTYX secukinumab Injection 125504 January 21, 2015 ⤷  Subscribe 2033-04-24
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.